Chiang, A., Loblaw, A., Jethava, V., Sethukavalan, P., Zhang, L., Vesprini, D., Mamedov, A., Nam, R., & Klotz, L. (2013). Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. Canadian Urological Association Journal, 7(11-12), 450–3. https://doi.org/10.5489/cuaj.262